| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| TETRAPHASE PHARMACEUTICALS | 27,283 | 25,075 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| LICENSES & FEES | 10 | 0 | 10 |